Search | Page 35 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Recurrent and Secondary MDS

    Is MDS that returns after treatment(s) have successfully controlled it considered recurrent MDS? The idea of the recurrent MDS is exactly that. If a patient’s MDS has been treated into remission or even control...

    Interview last updated 10/24/2012 - 1:12pm.

  2. From Natasha

    ... * Aplastic Anemia Myelodysplastic Syndromes Paroxysmal Nocturnal Hemoglobinuria Acute Myeloid Leukemia Other If ...

    Webform last updated 06/27/2016 - 2:13pm.

  3. ASH 2012 - Reviewing MDS Progress from Research and Clinical Perspectives

    Were there any presentations at ASH 2012 on the clinical aspects of MDS that you think patients might find particularly interesting? There is some evolution in the classification systems used for MDS. For y...

    Interview last updated 02/07/2013 - 1:28pm.

  4. Genetic Polymorphism of the Complement Receptor-1 (CR1) Gene Correlates with the Clinical Response to Eculizumab of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Original Publication Date:  Tuesday, January 1, 2013 Note: This review is based upon a presentation at the 2012 American Society of Hematology ...

    Research Review last updated 05/02/2016 - 9:25am.

  5. 2015 Bone Marrow Failure Disease Symposia

    ... myelodysplastic syndromes , aplastic anemia , paroxysmal nocturnal hemoglobinuria , and myeloproliferative neoplasms. The overall ...

    Page last updated 08/28/2015 - 2:23pm.

  6. Unrelated Donor Stem Cell Transplantation

    ... aplastic anemia paroxysmal nocturnal hemoglobinuria (PNH) ...

    Clinical Trial last updated 04/28/2016 - 2:16pm.

  7. ASH 2012 - Reviewing MDS Progress from Research and Clinical Perspectives

    We hear that there is increasing interest and research in the role that genes and genetic mutations have in affecting the course of MDS. Were there any studies of particular significance in this area? Yes, ...

    Interview last updated 02/01/2013 - 4:22pm.

  8. Senior Director of Patient Advocacy Programs

    ... anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria ( PNH ), and related bone marrow failure ...

    Page last updated 09/16/2015 - 10:40am.

  9. Director of Patient Education

    ... anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH), and related bone marrow failure ...

    Page last updated 09/16/2015 - 10:42am.

  10. IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia

    ... Bone Marrow Disease(s):  paroxysmal nocturnal hemoglobinuria (PNH) ...

    Clinical Trial last updated 04/29/2016 - 11:05am.